Published by Josh White on 30th December 2024
(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday, having enrolled its first patient.
URL: http://www.digitallook.com/dl/news/story/34781335/...